These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 30180910)

  • 1. miR-214 ameliorates acute kidney injury via targeting DKK3 and activating of Wnt/β-catenin signaling pathway.
    Zhu X; Li W; Li H
    Biol Res; 2018 Sep; 51(1):31. PubMed ID: 30180910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of miR-155 Ameliorates Acute Kidney Injury by Apoptosis Involving the Regulation on TCF4/Wnt/β-Catenin Pathway.
    Zhang XB; Chen X; Li DJ; Qi GN; Dai YQ; Gu J; Chen MQ; Hu S; Liu ZY; Yang ZM
    Nephron; 2019; 143(2):135-147. PubMed ID: 31216555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-182 enhances acute kidney injury by promoting apoptosis involving the targeting and regulation of TCF7L2/Wnt/β-catenins pathway.
    Li H; Ma Y; Chen B; Shi J
    Eur J Pharmacol; 2018 Jul; 831():20-27. PubMed ID: 29733821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC00052 ameliorates acute kidney injury by sponging miR-532-3p and activating the Wnt signaling pathway.
    Li X; Zheng P; Ji T; Tang B; Wang Y; Bai S
    Aging (Albany NY); 2020 Nov; 13(1):340-350. PubMed ID: 33231561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paracrine Activation of the Wnt/β-Catenin Pathway by Bone Marrow Stem Cell Attenuates Cisplatin-Induced Kidney Injury.
    Jiao X; Cai J; Yu X; Ding X
    Cell Physiol Biochem; 2017; 44(5):1980-1994. PubMed ID: 29237155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of miR-148b ameliorates myocardial ischemia/reperfusion injury via regulation of Wnt/β-catenin signaling pathway.
    Yang M; Kong DY; Chen JC
    J Cell Physiol; 2019 Aug; 234(10):17757-17766. PubMed ID: 30820984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of miR-21 by Ghrelin Ameliorates Ischemia/Reperfusion-Induced Acute Kidney Injury by Inhibiting Inflammation and Cell Apoptosis.
    Zhang W; Shu L
    DNA Cell Biol; 2016 Aug; 35(8):417-25. PubMed ID: 27152763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Exosomal miR-1-3p from Rats with Myocardial Infarction Plays a Protective Effect on Contrast-Induced Nephropathy via Targeting ATG13 and activating the AKT Signaling Pathway.
    Zhao P; Zhu Y; Sun L; Zhu W; Lu Y; Zhang J; Mao Y; Chen Q; Zhang F
    Int J Biol Sci; 2021; 17(4):972-985. PubMed ID: 33867822
    [No Abstract]   [Full Text] [Related]  

  • 9. MicroRNA-27a targets Sfrp1 to induce renal fibrosis in diabetic nephropathy by activating Wnt/β-Catenin signalling.
    Shi M; Tian P; Liu Z; Zhang F; Zhang Y; Qu L; Liu X; Wang Y; Zhou X; Xiao Y; Guo B
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32484208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Circ-Snrk ameliorates apoptosis and inflammation in acute kidney injury by regulating the MAPK pathway.
    Meng F; Chen Q; Gu S; Cui R; Ma Q; Cao R; Zhao M
    Ren Fail; 2022 Dec; 44(1):672-681. PubMed ID: 35416113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A16 promotes acute kidney injury by activating HRD1-induced ubiquitination and degradation of GSK3β and CK1α.
    Sun Y; Fan Y; Wang Z; Li M; Su D; Liu Y; Liang X
    Cell Mol Life Sci; 2022 Mar; 79(3):184. PubMed ID: 35279748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of miR-29a on diabetic glomerular dysfunction by modulation of DKK1/Wnt/β-catenin signaling.
    Hsu YC; Chang PJ; Ho C; Huang YT; Shih YH; Wang CJ; Lin CL
    Sci Rep; 2016 Jul; 6():30575. PubMed ID: 27460630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-423-5p inhibition alleviates cardiomyocyte apoptosis and mitochondrial dysfunction caused by hypoxia/reoxygenation through activation of the wnt/β-catenin signaling pathway via targeting MYBL2.
    Zhu X; Lu X
    J Cell Physiol; 2019 Dec; 234(12):22034-22043. PubMed ID: 31074036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated MicroRNA-25 Mediates the Migration of Melanoma Cells by Targeting DKK3 through the WNT/β-Catenin Pathway.
    Huo J; Zhang Y; Li R; Wang Y; Wu J; Zhang D
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effect of microRNA-107 targeting Dkk-1 by regulation of Wnt/β-catenin signaling pathway in osteosarcoma.
    Zhang ZC; Liu JX; Shao ZW; Pu FF; Wang BC; Wu Q; Zhang YK; Zeng XL; Guo XD; Yang SH; He TC
    Medicine (Baltimore); 2017 Jul; 96(27):e7245. PubMed ID: 28682874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-195-5p alleviates acute kidney injury through repression of inflammation and oxidative stress by targeting vascular endothelial growth factor A.
    Xu Y; Jiang W; Zhong L; Li H; Bai L; Chen X; Lin Y; Zheng D
    Aging (Albany NY); 2020 Jun; 12(11):10235-10245. PubMed ID: 32492657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DKK3 promotes renal fibrosis by increasing MFF-mediated mitochondrial dysfunction in Wnt/β-catenin pathway-dependent manner.
    Song J; Chen Y; Chen Y; Qiu M; Xiang W; Ke B; Fang X
    Ren Fail; 2024 Dec; 46(1):2343817. PubMed ID: 38682264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-95-3p promoted the development of prostatic cancer via regulating DKK3 and activating Wnt/β-catenin pathway.
    Xi M; Cheng L; Hua W; Zhou YL; Gao QL; Yang JX; Qi SY
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1002-1011. PubMed ID: 30779066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the role of MYCN in retinoblastoma by inhibiting p53 and activating wnt/βcatenin/Fra-1 signaling pathway by reducing DKK3.
    Chen X; Ouyang L; Ke N; Pi L; Zhou X
    Drug Dev Res; 2024 Aug; 85(5):e22222. PubMed ID: 39003564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
    Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J
    Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.